CANCER METASTATIC
Clinical trials for CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new CANCER METASTATIC trials appear
Sign up with your email to follow new studies for CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug begins human testing in advanced solid tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer drug called INV-1120, both by itself and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe dose levels a…
Matched conditions: CANCER METASTATIC
Phase: PHASE1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Targeted radiation tested for better cancer pain relief
Symptom relief Recruiting nowThis study compares two radiation treatments for people with painful bone metastases from cancer. It tests whether a more precise, targeted radiation (SBRT) provides better and longer-lasting pain relief than the standard radiation treatment (CRT). The trial will enroll 230 parti…
Matched conditions: CANCER METASTATIC
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Light-Activated bone glue offers new hope for pelvic fracture patients
Symptom relief Recruiting nowThis study is testing a special light-activated bone implant called IlluminOss to see if it helps reduce pain and improve movement in people with pelvic fractures. It's for two groups: cancer patients whose disease has spread to the bone and older adults with fragility fractures.…
Matched conditions: CANCER METASTATIC
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 18, 2026 18:25 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: CANCER METASTATIC
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC